BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 29, 2022
View Archived Issues
ProfoundBio presents novel ADCs for cancer treatment
Read More
University of California discloses new PRMT8 inhibitors
Read More
Vertex Pharmaceuticals patents CFTR potentiators
Read More
Dana-Farber Cancer Institute discloses new HER2 inhibitors
Read More
Merck & Co. presents DGAT-2 inhibitors
Read More
Idorsia Pharmaceuticals patents LGALS3 inhibitors
Read More
AC-0027875, a gamma-secretase modulator for the treatment of AD
Read More
To escape radiation, tumor cells reversibly damage their DNA
Read More
Discovery of pyrrolo-pyridine benzamide derivative with promising antitumor efficacy in vivo
Read More
Apramycin shows efficacy in models of Mycobacterium abscessus infections
Read More
Discovery of novel D4R antagonist with favorable in vivo PK profile
Read More
ProMIS reports potential therapeutic approaches for ALS and nominates lead candidate
Read More
Series A financing supports Kelonia's development of in vivo gene delivery technology
Read More
HanAll advances novel immuno-oncology antibodies HL-187/HL-186
Read More
Chimera Bioengineering advances preclinical testing of CAR-T therapy CBIO-007 for solid tumors
Read More